| Literature DB >> 34737599 |
Kutty Selva Nandakumar1, Dongzhou Liu2, Yong Chen2, Yanjuan Chen3, Li Zhao4, Hui He4, Laiyou Wei2, Wenjuan Lai2, Jingxia Yuan2, Xiaoping Hong2, Lixiong Liu2, Baojiang Wang5.
Abstract
PURPOSE: Inflamm-aging is a novel-concept in rheumatoid arthritis (RA) with accelerating aging process. We try to find a correlation between serum albumin/globulin (A/G) ratio and clinical biochemical parameters, incidence of aging-related diseases (ARDs) as well as inflammaging-related molecules. PATIENTS AND METHODS: Healthy controls (HC) and RA patients were compared with their clinical biochemical parameters including albumin and globulin levels, A/G ratio, and levels of serum lipids. Incidence of ARDs in RA was compared with A/G ratio, having a cut off value of 1.2. Expression levels of leptin and Trf2 genes in PBMCs, and inflammatory factors like IL-1β, IL-6, IL-8 and TNF-ɑ between HC and RA patients were compared, and correlated with the A/G ratio.Entities:
Keywords: age-related disease; biomarker; dyslipidemia; inflammation; leptin
Year: 2021 PMID: 34737599 PMCID: PMC8559238 DOI: 10.2147/JIR.S335671
Source DB: PubMed Journal: J Inflamm Res ISSN: 1178-7031
Figure 1Disturbed albumin and globulin levels in RA patients have significantly correlated with age and GFR. (A–C) Compared to HC (n = 38), RA patients (n = 134) had decreased albumin levels, while an increase in globulin levels was observed. Significantly lower A/G ratio was present in RA patients. (D) Albumin values negatively correlated with age in RA patients. (E) Albumin values positively correlated with GFR in RA patients. (F) A/G ratio had a significant negative correlation with age. (G) Albumin level also showed a negative correlation with age in HC. **p <0.01; ****p <0.0001.
Correlations Between Albumin, Globulin and A/G Ratio with Levels of ESR, CRP, Serum Lipids and Cytokines
| Variables | Albumin (g/L) | Globulin (g/L) | A/G | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 95% CI | 95% CI | 95% CI | |||||||
| Age (y/o) | 0.22 | [−0.35, −0.08] | −0.02 | [−0.16, 0.11] | 0.75 | −0.06 | [−0.20, 0.06] | 0.32 | |
| ESR (mm/h) | −0.46 | [−0.56, −0.34] | 0.53 | [0.42, 0.62] | −0.56 | [−0.65, −0.46] | |||
| CRP (mg/L) | −0.38 | [−0.49, −0.25] | 0.25 | [0.11, 0.37] | −0.37 | [−0.48, −0.24] | |||
| TC (mmol/L) | 0.32 | [0.16, 0.047] | −0.26 | [−0.41, −0.09] | 0.44 | [0.29, 0.57] | |||
| LDL (mmol/L) | 0.26 | [0.09, 0.41] | −0.14 | [−0.30, 0.03] | 0.1148 | 0.27 | [0.10, 0.42] | ||
| TG (mmol/L) | 0.15 | [−0.01, 0.32] | 0.0673 | 0.06 | [−0.10, 0.23] | 0.4634 | 0.03 | [−0.13, 0.20] | 0.6794 |
| HDL (mmol/L) | 0.23 | [0.06, 0.38] | −0.28 | [−0.43, −0.12] | 0.40 | [0.25, 0.53] | |||
| 0.12 | [−0.05, 0.29] | 0.1684 | −0.24 | [−0.40, −0.07] | 0.17 | [0.00, 0.34] | |||
| 0.09 | [−0.08, 0.26] | 0.2876 | −0.18 | [−0.34, −0.01] | 0.28 | [0.11, 0.43] | |||
| IL-6 (pg/mL) | −0.34 | [−0.52, −0.13] | 0.13 | [−0.08, 0.34] | 0.2268 | −0.31 | [−0.50, −0.10] | ||
| IL-8 (pg/mL) | −0.44 | [−0.60, −0.24] | 0.26 | [0.04, 0.45] | −0.44 | [−0.60, −0.24] | |||
| TNF-ɑ (pg/mL) | −0.51 | [−0.65, −0.33] | 0.31 | [0.10, 0.50] | −0.46 | [−0.62, −0.27] | |||
Notes: The bold p-values are less than 0.05, and indicate significant differences.
Abbreviations: A/G ratio, albumin to globulin ratio; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; IL, interleukin; TNF-ɑ, tumor necrosis factor-ɑ.
Figure 2Dyslipidemia in RA. (A–C) LDL level did not differ significantly between HC and RA, but both TC and HDL levels were higher in HC than RA. (D and E) CRP and TC had a negative correlation, whereas LDL, TC and HDL rarely showed any correlation with ESR and CRP. ns, not significant; **p <0.01; ****p <0.0001.
Figure 3Decreased A/G ratio as a presumptive marker for cardiovascular diseases and other ARDs in RA patients. (A) RA patients with CVD had a higher age range than those without CVD. (B) Age-matched data of patients with or without CVD. (C) HDL is lower in age-matched RA with CVD patients. (D–F) Higher globulin levels in RA patients with CVD manifested lower A/G ratio. (G and H), ESR and CRP had no significant differences between RA with or without CVD. (I) 16 patients with CVD, 8 with diabetes, 5 with cancer and 26 with OP were used in this study. In total, 44 patients were diagnosed with these ARDs. (J) Patients with A/G <1.2 had a higher risk for ARDs than patients with A/G >1.2. ns, not significant; *p <0.05; **p <0.01; ****p <0.0001.
Figure 4Relative expression of leptin and Trf2 mRNA levels in RA. (A) The relative expression of leptin mRNA level was increased in RA patients. (B) The relative expression of Trf2 mRNA level was decreased in RA patients. (C) An increased leptin level showed a moderate positive correlation with both TC and HDL levels in RA patients. (D) Leptin and Trf2 expression levels showed a strong positive correlation. ns, not significant; *p <0.05; **p <0.01.
Figure 5Inflamm-aging related cytokines increased in RA patients. (A and B) No significant differences between HC and RA in the insulin and leptin levels. (C–H) IL-6, IL-8, TNF-ɑ, NGF, IL-1, NGF and MCP-1 levels were increased in RA patients. ns, not significant; *p <0.05; **p <0.01; ****p <0.0001.